EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalised experience that patients demand require life sciences organisations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
Our Latest thinking
Navigating the digital wave: DTx regulations in Europe and beyond
Explore the evolving landscape of digital therapeutics (DTx) in Europe and beyond, focusing on regulatory frameworks, market access, and innovation strategies.
28 Mar 2025
Mark Chalmers
Why early preparation is essential for new health product regime
New regulatory regime promises significant benefits for patients and opportunities for manufacturers but only if the industry is prepared. Find out how.
04 Oct 2024
Mark Chalmers
How life sciences can make the right deals in a time of change
Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.
08 Jan 2024
Subin Baral
Why people are integral to successful transformations
EY teams discuss The Saїd Oxford EY research, and the impact people and human behaviour can have on the success and failure of transformations.
02 Mar 2023
Laura Flynn
How digital solutions enable value-based contracting for cell, gene therapies
Manufacturer and healthcare system collaboration and co-creation of solutions can support patient access to cell and gene therapies. Find out how.
28 Feb 2023
Are digital twins key to more personal, equitable and efficient care?
Digital patient twins tap into the transformative value data beyond the traditional medical to provide health providers and payers actionable insights. Learn more at ey.com/smarthealth.
25 Feb 2022
Kim Dalla Torre
How EY can Help
-
EY-Parthenon Health and Wellness Strategy Consulting teams help develop and deliver growth, transaction, digital and value creation strategies. We help health and life sciences organizations build greater financial and operational resilience and technical agility, supporting their future growth within an ever-changing landscape.
Read more -
Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more -
The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
The EY Life Sciences team
Direct to your inbox
Stay up to date with our Editor's picks newsletter.